Drug intelligence / Profile preview

VenaSilk

Development stage
Unknown
Lead developer
Laboratoire Innotech
Modality
Small Molecules
Administration
Topical
01

Overview

VenaSilk is a topical venotonic formulation developed by Laboratoire Innotech International for the symptomatic relief of chronic venous disease. The product is a cream-gel containing 2% diosmin, a bioflavonoid, and menthol. Diosmin is traditionally used in oral forms for its venotonic, vasculoprotective, and anti-inflammatory properties, which are mediated through the inhibition of catechol-O-methyltransferase (COMT), thereby prolonging the vasoconstrictive effect of norepinephrine on the vein wall. In this topical application, VenaSilk is designed to provide local venoprotective effects and protect the skin from factors contributing to venous insufficiency. The inclusion of menthol provides an immediate cooling sensation to alleviate symptoms such as leg heaviness and fatigue. The formulation is designed for twice-daily application and absorbs quickly without leaving a sticky residue.

Brand names
VenaSilk
Other names
Diosmin cream gelDiosmin topical
02

Targets

COMT (Catechol-O-methyltransferase)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on VenaSilk.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VenaSilk.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call